At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action Influenza virus sialidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 18 May 2001 Profile reviewed but no significant changes made
- 20 May 1998 No-Development-Reported for Influenza virus infections in Japan (Unknown route)
- 25 Sep 1995 New profile